[
  {
    "ts": null,
    "headline": "2 Beaten-Down Stocks to Buy and Hold",
    "summary": "Moderna has a deep pipeline of promising mRNA candidates that stand to boost business.  Regeneron is looking at label expansions for its main product as well as clinical progress elsewhere.  Here are two great examples to consider: Moderna (NASDAQ: MRNA) and Regeneron Pharmaceticals (NASDAQ: REGN).",
    "url": "https://finnhub.io/api/news?id=d997ab110453747799205f4839ec382006208458707934721f37ed2ad31debd9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751715900,
      "headline": "2 Beaten-Down Stocks to Buy and Hold",
      "id": 135766841,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Moderna has a deep pipeline of promising mRNA candidates that stand to boost business.  Regeneron is looking at label expansions for its main product as well as clinical progress elsewhere.  Here are two great examples to consider: Moderna (NASDAQ: MRNA) and Regeneron Pharmaceticals (NASDAQ: REGN).",
      "url": "https://finnhub.io/api/news?id=d997ab110453747799205f4839ec382006208458707934721f37ed2ad31debd9"
    }
  }
]